José Luís Arias Jiménez-rekin lankidetzan egindako argitalpenak (4)

2012

  1. Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: Application of individualized therapy in HIV-infected infants and toddlers

    British Journal of Clinical Pharmacology, Vol. 73, Núm. 4, pp. 641-650

2008

  1. Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

    Clinical Infectious Diseases, Vol. 46, Núm. 10, pp. 1601-1608

2005

  1. Mutations at codons 54 and 82 of HIV protease predict virological response of HIV-infected children on salvage lopinavir/ritonavir therapy

    Journal of Antimicrobial Chemotherapy, Vol. 56, Núm. 6, pp. 1081-1086

2004

  1. Virological phenotype switches under salvage therapy with lopinavir-ritonavir in heavily pretreated HIV-1 vertically infected children

    AIDS, Vol. 18, Núm. 2, pp. 247-255